Armodafinil (Nuvigil): Uses, Benefits, and Risks

Naomi Carr
Hailey Okamoto
Written by Naomi Carr on 08 December 2025
Medically reviewed by Hailey Okamoto on 20 February 2026

Armodafinil is a prescription stimulant medication used to improve daytime wakefulness, specifically in the context of certain disorders, such as narcolepsy and shift work disorder. It is generally a safe and effective medication when used as prescribed, although there may be risks of side effects, addiction, and overdose, particularly if it is misused.

Key takeaways:
  • Armodafinil (Nuvigil) helps to reduce sleepiness in people with narcolepsy or other conditions that cause excessive fatigue.
  • Armodafinil is a central nervous system stimulant, which contributes to its effects relating to alertness and wakefulness, but can also cause side effects.
  • Misusing armodafinil can result in addiction, dependence, and overdose, and it can be particularly harmful when combined with other substances.
a close up photo of a box labels Armodafinil on a teal background

Understanding armodafinil (Nuvigil) and how it works

Armodafinil is a central nervous system (CNS) stimulant that helps improve energy, memory, attention, and alertness, and reduces fatigue. The medication works by increasing the availability of neurochemicals like dopamine and norepinephrine in the brain. Generally, armodafinil is safe and well-tolerated when used as prescribed, although it does have some risk of abuse, addiction, and serious adverse effects.

Approved medical uses

Armodafinil (Nuvigil) is classed as a wakefulness-promoting agent. It is approved by the Food and Drug Administration (FDA) for use in adults who experience excessive daytime sleepiness related to obstructive sleep apnea (OSA), shift work disorder (SWD), or narcolepsy.

Off-label uses

Sometimes, doctors prescribe armodafinil for off-label purposes. This might include improving wakefulness or reducing fatigue in the context of the following:

As a nootropic (“smart drug”)

Armodafinil is sometimes used off-label as a nootropic or “smart drug” because it can enhance alertness, attention, and mental stamina. While some studies show improvements in working memory and executive function—especially in sleep-deprived individuals—this use is not FDA-approved, and safety has not been established for healthy users. Misuse can cause insomnia, anxiety, agitation, mood changes, and, in some cases, dependence or withdrawal. Because armodafinil interacts with many medications and has long-lasting stimulant effects, off-label cognitive use carries meaningful risks and should be approached with caution.

Dosage and administration guidelines

Armodafinil is available as a generic medication and a brand-name form, Nuvigil. It is available as a tablet in varying strengths, ranging from 50 mg to 250 mg.  

Armodafinil is administered as an oral tablet. A recommended dose for OSA or narcolepsy is between 150 mg and 250 mg, taken in one morning dose. The recommended dosage for SWD is 150 mg, to be taken around one hour before the start of the work shift.

Effectiveness and benefits

Armodafinil can be an effective and safe treatment for people with narcolepsy, SWD, and OSA, and has been found to be safe in long-term treatment of one year or more. Typically, adverse effects are mild and well-tolerated, although some individuals may require increased monitoring of blood pressure during treatment, and some may experience serious adverse effects.

Armodafinil is a modified version of modafinil. Both medications work as wakefulness-promoting agents. However, armodafinil lasts longer than modafinil, and therefore, may be a more helpful and appropriate medication for those with persistent excessive sleepiness.

Armodafinil's duration of effects

The effects of armodafinil last up to 13.5 hours, although it can take 2-3 days for the drug to be completely eliminated from the body. The half-life for armodafinil is approximately 15 hours, meaning that 50% of the drug is still in the bloodstream after 15 hours of administration.

Side effects and risks

When starting armodafinil treatment, it is common to experience some side effects. Typically, these will go away without the need for intervention. However, if any of the following side effects persist for longer than a few weeks or get worse, contact a doctor. Because armodafinil is a powerful and long-lasting stimulant, the most common side effect of the drug involves trouble falling asleep and staying asleep.

Other common side effects of armodafinil include:

  • Dizziness
  • Headache
  • Dry mouth
  • Tingling or numbness in hands or feet
  • Impaired concentration
  • Shaking
  • Nausea or vomiting
  • Diarrhea
  • Constipation
  • Stomach pain
  • Reduced appetite
  • Increased thirst
  • Sweating
  • Increased urination 
  • Anxiety 
  • Low mood
  • Agitation
  • Increased heart rate

Serious side effects

In some cases, serious side effects can occur, which may require a change in dosage or medication, and should be reported to the prescribing doctor immediately. Serious side effects of armodafinil can include:

  • Rash, blisters, or hives
  • Itching or peeling skin
  • Swelling of the mouth, face, or limbs
  • Trouble breathing or swallowing
  • Extreme changes in heart rate, including irregularities or a pounding heartbeat
  • Chest pain
  • Weakness
  • Extreme changes in mood, including severe anxiety or depression
  • Hallucinations
  • Suicidal thoughts or behaviors
  • Manic symptoms

Taking more armodafinil than prescribed, or using it alongside other substances, can cause overdose. Armodafinil overdose symptoms can include changes in mood and behavior, issues with cardiac function, and digestive issues. Armodafinil overdose can be fatal, whether taken alone or alongside other substances.

Is armodafinil addictive?

There are reports of people abusing armodafinil for its euphoric effects and impact on alertness, mood, and perception. These effects can contribute to the use of larger and more frequent doses, using armodafinil without a prescription, or seeking multiple prescriptions from different doctors.

Similarly, prolonged armodafinil use can lead to the development of physical dependence and tolerance. This can cause individuals to use increasing doses to achieve the same effects and can lead to withdrawal symptoms when use is stopped. These behaviors can contribute to the development of addiction and can increase the risk of adverse effects and overdose.

Withdrawal and misuse signs

Signs of misuse can include taking bigger or more frequent doses than prescribed, strong urges to use, inability to control use, and negative consequences related to use of the drug. Armodafinil withdrawal symptoms can occur when the medication is stopped. Withdrawal symptoms can include shaking, sweating, chills, fever, confusion, nausea and vomiting, and aggression. Severe withdrawal, which may be more likely to occur after abruptly stopping prolonged use, can include seizures, insomnia, depression, and suicidal thoughts.

Safety precautions and drug interactions

Armodafinil may not be suitable for certain populations or may require use with caution and in reduced doses. This can include:

Armodafinil can interact with other substances, which may cause reduced medication effectiveness and increased risks of adverse effects. It is important to discuss recent and current medications and supplements with the prescribing doctor before commencing armodafinil.

Medication interactions with armodafinil include omeprazole, some contraceptives, benzodiazepines, beta blockers, some antidepressants, and some anticonvulsants. It is also recommended to avoid alcohol while taking armodafinil.

Is armodafinil a controlled substance?

Armodafinil is a Schedule IV controlled substance. Controlled substances are listed from Schedule I to V depending on their potential for abuse, addiction, and harm. Armodafinil is Schedule IV, meaning that it carries some risk of addiction and abuse.

Balancing benefits and safety

All drugs carry some risks for adverse effects, which need to be carefully weighed against the benefits. Excessive sleepiness can have significant detrimental impacts on a person’s functioning, mood, and well-being. Untreated excessive sleepiness can cause serious harm and an increased risk of accidents, and these risks may be reduced by taking a stimulant medication like armodafinil.

Many people safely take armodafinil and benefit from its effects with minimal side effects. However, for others, the risks could outweigh the benefits. This may be particularly true for people with certain underlying health conditions and those who experience unwanted side effects. In these cases, alternative treatment options may be necessary.

Before commencing armodafinil, discuss with the prescribing doctor any history of physical or mental health issues, substance use issues, and medication or supplement use. This can help to reduce risks and determine whether armodafinil is an appropriate treatment. 

Always use armodafinil exactly as prescribed. Never take more than prescribed or alter the dosage without professional guidance. Not all side effects start immediately, so it’s important to monitor for changes on an ongoing basis and discuss any issues or concerns with your prescriber, even if you’re unsure if they’re related to the medication.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Cephalon, Inc. (Revised 2017). Nuvigil (Armodafinil) Tablets. FDA. Retrieved from
  2. Black, J.E., Hull, S.G., Tiller, J., Yang, R., & Harsh, J.R. (2010). The Long-Term Tolerability and Efficacy of Armodafinil in Patients with Excessive Sleepiness Associated with Treated Obstructive Sleep Apnea, Shift Work Disorder, or Narcolepsy: An Open-Label Extension Study. Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine6(5), 458–466. Retrieved from
  3. National Institutes of Health. (Revised 2023). Armodafinil. Medline Plus. Retrieved from
  4. Shirley, K., & Servid, S. (Reviewed 2015). Off-Label Use of Modafinil (Provigil) and Armodafinil (Nuvigil). Oregon State University. Retrieved from
  5. Lamas-Aguilar, R., Diaz-Ruiz, A., Navarro, L., Miranda-Ojeda, R., de Los Ángeles Martínez-Cárdenas, M., Mata-Bermudez, A., & Rios, C. (2024). Armodafinil as a Potential Pharmacological Treatment for Attention Deficit Hyperactivity Disorder in Adults: A Review. Current Neuropharmacology22(11), 1899–1908. Retrieved from
  6. Rosenberg, R., & Bogan, R. (2010). Armodafinil in the treatment of excessive sleepiness. Nature and science of sleep2, 95–105. Retrieved from
  7. Russo, M. (2009). Pharmacotherapy of Excessive Sleepiness: Focus on Armodafinil. Clinical Medicine Therapeutics, 1(7), 415-432. Retrieved from

Activity History - Last updated: 20 February 2026, Published date:


Reviewer

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Hailey Okamoto is a Licensed Clinical Mental Health Counselor, Licensed Clinical Addiction Specialist, and Certified Clinical Supervisor with extensive experience in counseling people with mental health and addictive disorders.

Activity History - Medically Reviewed on 08 December 2025 and last checked on 20 February 2026

Medically reviewed by
Hailey Okamoto

Hailey Okamoto

M.Ed, LCMHCS, LCAS, CCS

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (833) 840-1202
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

More like this